Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma
Clinical trial NCT00843310 · TERMINATED
Trial details
- NCT number
- NCT00843310
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-10-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.